EyePoint Pharmaceuticals Inc
0.0 %
-70.22 %
Yet to be announced
Company Overview
EyePoint Pharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing therapeutics for ocular disorders. The company specializes in innovative sustained-release drug delivery products for treating serious eye diseases. Their portfolio includes approved products for treatment of chronic eye diseases and a pipeline of candidates in clinical development.
Revenue Sources
Based on review of EyePoint Pharmaceuticals' business model and revenue sources, their income is derived from the development and sale of therapeutic treatments for eye diseases. These products and services are permissible from an Islamic perspective as they provide legitimate medical benefits and do not involve prohibited substances or gambling activities.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $10.52m | $43.27m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $9.48m | $44.02m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $11.68m | $45.01m | - | - | 0.00% | 0.00% |
| Dec. 31, 2023 | $14.03m | $30.38m | - | - | 0.00% | 0.00% |
Looking at the financial statements for the past four quarters, EyePoint Pharmaceuticals shows no interest income or interest expense. The company is still in development phase with its main products, which is typical for pharmaceutical companies. Given the pre-mature operational stage and absence of interest-based income or expenses, this criterion is passed.
Operational Ethics
Based on available information from SEC filings and company disclosures, there is no evidence of material ongoing associations with entities involved in human rights violations. The company's operations are primarily focused in the United States, with no indication of significant ties to Israel or the Chinese Communist Party.
Login to join the discussion